| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.03 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.03 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |